Lung cancer management in the COVID-19 pandemic

Abstract

Covid-19 infection, spreading from China to the whole world, continues to spread and cause serious mortality. Covid-19 infection causes mortality with pneumonia due to severe lung involvement, ARDS and respiratory failure. Lung cancer causes both a decrease in the local resistance of the lung and an increased risk in cases against secondary infections such as Covid-19 pneumonia with immunosuppression that may occur during the treatment period. In the course of Covid-19 infection, cancer and other serious comorbidities cause high rates of severe clinical picture, intensive care admission and mortality. During Covid-19 pandemic, cancer and other serious co-morbidities; It causes high rates of severe clinical picture, intensive care admission and mortality. It is recommended to evaluate patients with lung cancer individually and to plan the treatment according to their stages and performances. During the pandemic process, it should be planned to use non-invasive radiological methods instead of endobronchial interventional examinations in the diagnosis, to minimize